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ABSTRACT
Introduction: The electronic cigarette (EC) usage has raised public health concerns; whether its advantages to smok-
ers as a potential smoking cessation aid have outweighed its negative health impacts among EC users. This study 
aims to estimate health risks associated with chemical exposures to nicotine, propylene glycol (PG) and selected To-
bacco-Specific Nitrosamines (TSNAs) namely 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N’-nitro-
sonornicotine (NNN) in e-liquids locally-manufactured in Malaysia. Methods: The health risk assessment (HRA) was 
performed using established guideline by the Environmental Protection Agency (EPA). The average daily dose (ADD) 
and lifetime average daily dose (LADD) were calculated using previously published data on chemical concentration 
of selected compounds and local EC usage topography data. Next, the non-carcinogenic risk (nicotine and PG) and 
carcinogenic risk (NNK and NNN) were calculated and denoted as total hazard quotient (HQ
T
) and total lifetime 
cancer risk (LCR
T
) value, respectively. Results: For non-carcinogenic risk, the mean of HQ
T
 was 78.9 which falls un-
der “unacceptable” risk as demonstrated by HQ
T
 value of more than 1. While for carcinogenic risk, the mean of total 
LCR
T
 value was 1.54E-04 which may place EC users at risk of developing cancer resulted from exposure to selected 
TSNAs. Conclusion: Comprehensive HRA using currently available data of local EC usage topography and chemical 
evaluation of Malaysian-made e-liquids have revealed that the exposure to nicotine, PG and selected TSNAs are 
expected to be a significant health concern for local EC users. This finding supports the local health authority to issue 
a stringent health policy in considering EC as a tool for smoking cessation among heavy smokers.
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INTRODUCTION
The emergence of electronic cigarette (EC) or electronic 
nicotine delivery system (ENDS) in the market has called 
upon the public health concerns pertaining to its safety 
and potential harm to health. Despite the uncertainty on 
its health effects, there are evidences of its potential use 
as a smoking cessation aid for smokers to quit smoking 
(1,2). Nevertheless, there are reports in Canada that 
the EC has become an experimenting device for young 
adults who never smokes (3) and a report in Malaysia 
reported similar findings (4). A previous multi-country 
study reported that Malaysia had among the highest 
percentage of current EC users (14%) (5). The finding 
also showed that there were 15% smokers who were 
dual-users who also use conventional cigarettes in 
addition to EC. A small sub-community study in Malaysia 
has shown that most EC users believed vaping was safer 
than using conventional cigarettes (87%) and existing 
tobacco smokers stated the reason for vaping was to 
reduce tobacco consumption (81%) (6). A small fraction 
of the sample population was previously non-smokers 
(3.9%) (6) which reinforce previous findings about EC 
usage not limited  to existing traditional tobacco users 
only (7).
E-liquids locally produced are widely available in the 
Malaysian market (6). E-liquids are easily accessible 
and can be either purchased from physical vape shops, 
online shops or night markets with loose restriction. In 
addition, it has been sold without quality assurance, 
particularly on the accuracy of labelling of its chemical 
contents. Currently, e-liquids that contain nicotine are 
regulated under Section 9(1) Poison Act 1952 (8). Under 
the law, nicotine is categorised as a poison in Group C 
in which it should only be sold as “dispensed medicine” 
by licensed pharmacists and the sale of products are 
regulated by Ministry of Health. While, the Ministry 
of Domestic Trade, Cooperatives and Consumerism is 
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responsible to regulate and enforce the safety standards 
of EC device as well as the labelling of nicotine-free 
e-liquids. However, the restriction and e-liquid products’ 
terms of sale are still unclear. 
The acceptance of the EC and the use of locally-
manufactured e-liquids among the public have 
created the need to perform health risk assessment. 
Existing study has shown that e-liquids contain TSNAs 
(9) which are the most potent chemical classified as 
Group 1 human carcinogen by International Agency for 
Research on Cancer (IARC) (10) while nicotine is the 
most addictive agent in tobacco products. The selected 
TSNAs have been detected in e-liquid samples in the 
range from 0.22 to 9.84 µg/L for 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone (NNK) and 0.34 to 60.08 µg/L 
for N’-nitrosonornicotine (NNN) (9). In addition, there 
is the issue with labelling discrepancies on nicotine 
content which has previously been reported in literature 
[range of percentage difference between the labelled- 
and measured concentration of nicotine = -27% to -73% 
difference (11) and -32.2% to 3.3% difference; (12)]. All 
these evidences demonstrate the ability of EC to pose 
detrimental health effects of either carcinogenic or non-
carcinogenic impact to its users.
The knowledge gap on the health risk assessment (HRA) 
in regards to EC use, incorporated with an increasing 
number of users among Malaysian populations have 
warranted further investigation on this public health 
issue. Assessment of health risks performed using 
local EC topography data is important because data 
on estimated risk may be used in health promotion 
activities or in conveying or communicating information 
on the potential hazards arising from EC use especially 
among younger population. There is the need to address 
health promotion activities according to its hierarchical 
importance; the first is that e-liquids with labelling 
discrepancies may expose younger population who 
uses EC for experimenting purposes become  addicted 
to nicotine and may end up as conventional cigarette 
smokers in the future (13). This is followed by the need 
to continue to reduce the prevalence of current smokers 
as specified in the Framework Convention of Tobacco 
Control (14). No other studies have attempted to estimate 
the risks associated with the use of locally-manufactured 
e-liquids, especially the products most-favoured among 
local users. Therefore, this study aims to assess human 
health risk for non-carcinogenic and carcinogenic 
effects resulting from the exposure to nicotine, PG and 
selected TSNAs contained in the locally-manufactured 
e-liquids. It is expected that the findings of this study will 
assist the authority to develop an evidence-based policy 
and a framework on EC regulation. 
MATERIALS AND METHODS
This health risk assessment (HRA) study was a part of 
larger study of a survey on the use of EC conducted 
among 86 adult tobacco users in several areas in 
the Klang Valley, Malaysia. Being one of the most 
concentrated areas of EC users (15), the selection of 
Klang Valley as a study location was the most relevant. 
The results of the survey were previously published 
elsewhere (6). To recap briefly, a survey on EC use 
has been conducted among 226 tobacco users who 
purposively sampled among selected populations of 
adults in Klang Valley area. Three survey dissemination 
approaches have been applied in order to obtain the 
sufficient number of respondents, namely the university-
based, company-based and online-based approach. The 
data on EC usage topography was collected among 86 
of EC users who identified during the survey. The EC 
usage topography data consisted of i) usage duration 
(median: <1 year); ii) volume of e-liquid used per 
month (60 mL/month); and iii) no. of puff per day (50 
puffs/day). The study also was able to identify 17 most-
favoured locally manufactured e-liquids. The e- liquids 
were analysed using previously established methods 
(9,16) to determine the concentration of nicotine, PG 
and selected TSNAs and were previously published in 
the literature (11).
HRA was performed using an established method 
proposed by United States Environmental Protection 
Agency (17). This method has been applied in other 
studies to estimate health risks resulting from exposures 
to selected chemicals at the population level (18,19). 
In this study, the probability of detrimental health 
effects occurring as a result of the exposure to selected 
chemicals contained in locally-manufactured e-liquids 
determined in a separate study (11) were calculated 
based on the approach established by the United States 
of Environmental Protection Agency (USEPA) (20). This 
method integrates analytical measurements of chemicals 
with topography data to come out with population-
based health risks.
For the health risks associated with the 17 e-liquids, 
estimations were made on i) non-carcinogenic health 
effects due to exposure to nicotine and PG content and 
ii) carcinogenic health effects due to exposure to NNK 
and NNN. Non-carcinogenic health effects include 
cough, dry mouth and throat, throat irritation, nausea, 
dizziness, and emphysema. 
In order to estimate the health risks of non-carcinogenic 
health effects resulted from nicotine and PG exposures, 
the average daily dose (ADD) were calculated using 
equation 1 for individual compounds. 
 ADD = Cp x IR x ED x EF
    BW x ATNC                                           
[Equation 1]
In equation 1, Cp is average concentration of chemical 
in e-liquid (mg/mL); IR is ingestion rate (mL/day); ED is 
exposure duration (year); EF is exposure frequency (day/
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year); BW is average of body weight of respondents (kg); 
ATNC is averaging time (EDx365 days/year) for non-
carcinogenic effects. The HQ value was determined 
using equation 2. The RfD values for nicotine and PG 
were as established value by European Food Safety 
Authorities (20) and Agency for Toxic Substances and 
Disease Registry (22), respectively. 
HQ = ADD (mg⁄kg/day)                               [Equation 2]
          RfD (mg/kg/day)                                        
In equation 2, ADD is the average daily dose of 
population (mg/kg/day) and RfD is the reference dose 
for particular non-carcinogenic chemical constituents 
(mg/kg/day). The final outcome of the HRA for non-
carcinogenic health effect is the characterisation of 
HQ value. The value would determine whether the 
exposure to the compound was; i) not likely to attribute 
to non-carcinogenic health effect which interpreted as 
“acceptable risk”/ (HQ value was less than 1) or ii) likely 
to contribute to non-carcinogenic health effect which 
interpreted as “unacceptable risk” when the HQ value 
was more than 1. The sum of individual HQ of nicotine 
and PG exposures would be expressed as total HQ 
(HQ
T
).
For carcinogenic health risk, lifetime average daily 
dose (LADD) values were estimated as the result of 
respondents’ exposure to NNK and NNN contained in 
locally-manufactured e-liquids. Equation 3 was applied 
to determine the LADD values.  
LADD =  Cp x IR x Ed x EF                          [Equation 3]
         BW x ATC
                                   
In equation 3, Cp is the average concentration of 
chemical in e-liquid (µg/L); IR is the ingestion rate (L/day); 
ED is the exposure duration (year); EF is the exposure 
frequency (day/year); BW is the average body weight 
of respondents (kg); ATC is the averaging time (70x365 
days/year) for carcinogenic effects. The LCR calculation 
in equation 4 considers the value of respective cancer 
slope factor (CSF) for each carcinogenic compound 
which were derived from the California Office of 
Environmental Health Hazard Assessment (23).  
LCR = LADD x CSF                                               [Equation 4]
In equation 4, LADD is the lifetime average daily dose 
(µg/kg/day); CSF is the cancer slope factor for each 
carcinogenic chemical constituents. The carcinogenic 
health risk which was denoted by LCR value would 
be interpreted as; i) clearly acceptable if the value was 
less than 1.0E-6; ii) acceptable if the value fall within 
1.0E-6 to 1.0E-4 and iii) clearly unacceptable when the 
value was more than 1.0E-4. Total LCR (LCR
T
) would 
be the sum of individual LCR value of NNN and NNK 
exposures.  Table I shows the parameters used for the 
calculation of ADD, LADD, HQ and LCR.
RESULTS
The assessment of health risks related to EC usage 
resulting from the exposure to nicotine, PG and 
selected TSNAs contained in the locally manufactured 
e-liquids were performed according to the EC usage 
topography information and selected chemical analysis 
data as published previously (6,11). Prior to step of risk 
characterization, the dose of exposure (ADD & LADD) 
to chemicals was calculated as described in Table II 
using equation 1 and 3. 
Table I: Parameters used in the estimation of ADDa, LADDb, HQc, 
and LCRd
Parameter Value Reference
Measured concentra-
tion (Cp)
mean (standard devi-
ation)
i) Nicotine = 3.26 (1.04) mg/mL (11)
ii) PG= 484.10 (98.24) mg/mL (11)
iii) NNKe = 0.085 (0.057) µg/L (11)
iv) NNNf = 0.0377 (0.289) µg/L (11)
Ingestion rate (IR) 2 mL/day (6)
Exposure duration (ED) 1.04 year (6)
Exposure frequency (EF) 260 day/year (6)
Body weight (BW) 73.86 kg (6)
Averaging Time (AT) Non-cancerg = 379.6 
Cancerh = 25550 
-
Reference dose (RfD) i) Nicotine = 0.0008mg/kg/day (21)
ii) PG = 25mg/kg/day (22)
Cancer slope factor 
(CSF)
i) NNK = 1.81 x 10-9µg/kg/day (23)
ii) NNN = 1.4 mg/kg/day (23)
aAverage daily dose; bLifetime average daily dose; cHazard quotient; dLifetime cancer risk 
eNNK = 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; fNNN = N’-nitrosonornicotine; gAT 
for non-cancer risk = ED*365; hAT for cancer risk = 70 years*365 
Table II: Dose of exposure to selected chemicals
No. Compound ADDa (mg/kg/day) LADDb (µg/kg/day)
Nicotine 0.063 NA*
PG 9.338 NA
NNN NA 1.098E-7 
NNK NA 2.45994E-08 
*Not applicable; aADD (average daily dose) = (refer equation 1);bLADD (lifetime average daily 
dose) = (refer equation 3)
The mean value of LCR
T
 was 1.54E-04 which slightly 
exceeds the acceptable risk threshold of 1E-4. Figure 
1 presents the box plots of (a) individual LCR of NNK; 
(b) individual LCR of NNN; and (c) Total LCR of NNN 
and NNK. Based on Figure 1, it was estimated that the 
population will be at risk of developing cancer due to 
exposure to selected TSNAs (NNN and NNK). Total 
LCR value has exceeded the acceptable value of more 
than 1E-4. Specifically, according to the total LCR 
value (LCR
T
), a ratio of 2 persons over 10,000 of user 
population will be at risk of cancer.
Figure 2 demonstrates the box plots of (a) individual HQ 
of PG; (b) individual HQ of nicotine; and (c) total HQ 
of PG and nicotine. For non-carcinogenic health risks, 
the HQ
T
 was 78.9 (Figure 2 (c)) which exceeded the 
acceptable level of 1. It is estimated that the population 
were at risk of experiencing non-carcinogenic health 
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effects due to exposure to nicotine and PG contained 
in e-liquids.  
DISCUSSION
This study aimed to estimate the carcinogenic and non-
carcinogenic health risks arising from the exposure to 
nicotine, PG and selected TSNAs related to the use of EC 
and locally-manufactured e-liquids. This study estimates 
that two out of 10,000 EC user populations will be at 
risk of experiencing cancer effects due to cumulative 
exposure to NNN and NNK identified in the locally-
manufactured e-liquids. The study shows that the total 
exposure to nicotine and PG contained in e-liquids were 
able to expose EC users to the risk of non-carcinogenic 
health effects. 
In order to estimate the risk of EC, multiple approaches 
have been applied (24). However, many of previous 
studies (25,26) have presented the finding on the 
chemical constituents contained either in the e-liquid or 
vapor, without emphasizing on the carcinogenic or non-
carcinogenic health risk that could be attributed from the 
exposure to selected chemical contents. In the present 
study, the health risk of local population was estimated 
based on their EC usage topography data and included 
the chemical analysis of the most-favoured locally-
Figure 1: Box plots of (a) individual LCR of NNK; (b) individu-
al LCR of NNN; and (c) Total LCR of NNK and NNN
manufactured e-liquids. The methodology of performing 
health risk estimation has provided an advantage in 
the present study to stand as a comprehensive HRA in 
order to address the health risk encountered by local 
population.  
Despite being advertised as harmless (27,28), this study 
has added the evidence of the potential non-cancer 
health effects of EC that could be experienced by the 
users due to cumulative exposure of nicotine and PG in 
e-liquid. Within the Malaysian context, the EC has not 
only been used among smokers, but it was also smoked 
by previously never-smokers who initially used EC for 
enjoyment purposes. The entry of EC into the Malaysian 
market has contributed to the involvement of never-
smokers as a new group of tobacco users which may have 
prevented the reduction in the number of local smoking 
population. As reported in the 21,410 representative 
Malaysian populations-based survey, National Health 
Morbidity Survey (NHMS), smoking-related diseases 
have contributed about one-fifth of disability adjusted 
life years (DALYs) and one-third of years of life lost 
(YLL) among Malaysian (29,30). Therefore, the use of 
EC including dual-users and those who never previously 
smoke may indirectly contribute to the national burden 
of tobacco/smoking-related diseases in Malaysia. 
Multiple health effects, particularly symptoms related to 
the respiratory system have been reported such as dry 
mouth and throat, and cough among EC users (31,32). 
The occurrence of these symptoms may be due to the 
hygroscopic property of PG where this relates to the 
ability of PG absorb moisture in its surroundings causing 
the dryness of mouth and throat once the vapour was 
inhaled by users (33). Equally important, the findings 
suggest that there is the probability of TSNAs in e-liquids 
posing cancer risks to EC users in a ratio of 2 persons 
over 10,000 of EC user populations. As reported in pre-
clinical studies, the exposure to NNK has been related 
to lung cancer risk (34,35) while NNN exposure has 
posed a risk of esophageal and oral cavity cancer (36). 
Therefore, the use of EC, especially among the group of 
users who previously have never smoked is of significant 
concern.
Although the device has been deemed as a harm-
reduction tool (37), it has been surrounded by 
controversial issues such as its potential in promoting 
tobacco use among the younger population. The trend of 
youth smoking since 2003 (19.9%) (38) to 2006 (6.1%) 
(39) has been on the decline, but from the data, it clearly 
shows that there was a large incline of percentage from 
2012 (11.5%) (40) to 2017 (13.8%) (41) with reasons not 
explained. The emergence of EC as a new-technology 
in delivering nicotine may to some extent contribute 
to that increment. Other studies have reported that 
the younger population may be keen to try EC due to 
curiosity and the myriad varieties of e-liquid flavours 
currently available in the market (42,43) which later 
may facilitate initiation of nicotine dependence among 
Figure 2: Box plots of (a) Individual HQ of PG; (b) Individual 
HQ of nicotine; & (c) Total HQ of PG and Nicotine
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delivery device has challenged the government’s 
approach to accomplish the mission of having less than 
15% of smoker by 2045. The acceptance of EC use 
among the public (5,50) interrupts the health promotion 
objectives performed by the government to de-normalise 
smoking habit, thus, it may contribute to initiation of 
tobacco use among non-smokers.
The limitation of this study includes the fact that the 
health risk assessment was performed based on oral 
ingestion rather than inhalation exposure. At present, 
there are no existing HRA data published involving 
local EC products and there was no access to smoking 
machine at the commencement of this study. As such, 
this is the best available local data produced to represent 
the potential adverse health effects to EC users; which is 
the main concern in the area of public health. Due to 
this limitation, data should be interpreted with caution. 
Further assessment using inhalation exposure data 
should be performed in the future once data are made 
available. Notwithstanding the limitation, the estimation 
of the health risks was performed based on the real EC 
usage topography of this population and the chemical 
analysis was conducted for the most-favoured locally 
manufactured e-liquids. Thus, this study has been 
conducted in a comprehensive approach in evaluating 
the potential human health risk as an outcome of 
exposure to nicotine, PG and selected TSNAs from the 
use of EC.
CONCLUSION
This study estimates that EC use has the potential to 
contribute to non-cancer and cancer risk to the health 
of its users. The findings of this study will assist the 
local related authority to come out with evidence-based 
policies on EC, in order to combat the rising of tobacco-
related morbidity and mortality and prevent tobacco use 
initiation among the population to reach the national 
goal of End Game for tobacco by 2045.
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